LSA (Morning Glory) in Solomon Islands: not individually verified

Also known as: hawaiian baby woodrose

We have not confirmed that LSA (Morning Glory) specifically is scheduled in Solomon Islands, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record

Not confirmed. No entry for LSA (lysergic acid amide) was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98) reprint as in force at 1 October 2009 (text); the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) and the further proclamation LN 6 of 1988 (the margin of printed page 2824 reads LN 61/1988, while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988), read from the page images of printed pages 2821 to 2824 of the 1996 Revised Edition; the Pharmacy and Poisons Act (Cap. 105) reprint as in force at 5 February 2024, including Schedule A and Schedule B (the Poisons List, Parts I and II); the Poisons Rules made under section 61 of that Act, as printed in the 1996 Revised Edition (printed pages 3000 to 3043, margin notes amended to LN 63 of 1988), read from the page images, including the First Schedule and the Fourth Schedule of substances sold by retail only on a prescription; and the Dangerous Drugs (Methylamphetamine) Rules 2025 (Gazette No. 158, 5 November 2025). Terms searched: LSA, lysergic acid amide, ergine, lysergic, ergot, Claviceps, ololiuqui, morning glory, Argyreia, Ipomoea. Result: no entry for LSA or any lysergic acid in the proclamation schedules or the Act. The Poisons List in Schedule B Part I names 'Ergot; alkaloids of' among the alkaloids, and 'Ergot (the sclerotia of any species of Claviceps); extracts of ergot; tinctures of ergot'. The Fourth Schedule lists 'Ergometrine', 'Ergotamine', 'Methylergometrine', 'Methysergide' and 'Dihydroergotamine' as separate entries, and no LSA. No printed entry names LSA. Whether LSA is an alkaloid 'of' ergot is not stated by any instrument read, so no verdict is given on it. Conditional: if LSA is an alkaloid of ergot, the Part I entry 'Ergot; alkaloids of' and the First Schedule entry 'Ergot, alkaloids of' (Poisons Rules, 1996 Revised Edition, printed page 3013) apply to it, and sale would be limited as for any Part I poison to an authorised seller by or under the supervision of a registered pharmacist (section 56(1)(a)); that would be a pharmacy sale restriction and not drug control. Seeds of morning glory plants are not named in any instrument read. The control model for dangerous drugs is delegated. Section 2 of the Dangerous Drugs Act defines a dangerous drug as any of the substances which may be from time to time subject to the provisions of the Act, and section 13(2) lets the Minister by proclamation apply Part III to further drugs. That power has been exercised more than once (LN 101 of 1987, LN 6 of 1988, and the 2025 Rules made under section 15 and those two proclamations). The reprint lists only Act No. 14 of 2009 in its endnotes and carries no line closing its subsidiary legislation, and proclamations or rules made after the 1996 edition were not all read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament and was not read; a Bill is not law. Absence from the instruments read is therefore not a finding that LSA (lysergic acid amide) is uncontrolled, legal or unregulated, and no verdict is given. Not established: whether any instrument not read names it.

Confirm directly with Solomon Islands’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.